STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

Oncogene. 2016 Aug 18;35(33):4388-98. doi: 10.1038/onc.2015.446. Epub 2015 Nov 30.

Abstract

Smad and STAT proteins are critical signal transducers and transcription factors in controlling cell growth and tumorigenesis. Here we report that the STAT3 signaling pathway attenuates transforming growth factor-β (TGF-β)-induced responses through a direct Smad3-STAT3 interplay. Activated STAT3 blunts TGF-β-mediated signaling. Depletion of STAT3 promotes TGF-β-mediated transcriptional and physiological responses, including cell cycle arrest, apoptosis and epithelial-to-mesenchymal transition. STAT3 directly interacts with Smad3 in vivo and in vitro, resulting in attenuation of the Smad3-Smad4 complex formation and suppression of DNA-binding ability of Smad3. The N-terminal region of DNA-binding domain of STAT3 is responsible for the STAT3-Smad3 interaction and also indispensable for STAT3-mediated inhibition of TGF-β signaling. Thus, our finding illustrates a direct crosstalk between the STAT3 and Smad3 signaling pathways that may contribute to tumor development and inflammation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Differentiation
  • Epidermal Growth Factor / pharmacology
  • Epithelial-Mesenchymal Transition
  • HEK293 Cells
  • Humans
  • Interleukin-6 / pharmacology
  • STAT3 Transcription Factor / physiology*
  • Signal Transduction / physiology
  • Smad3 Protein / physiology*
  • Th17 Cells / cytology
  • Transforming Growth Factor beta / antagonists & inhibitors*
  • Transforming Growth Factor beta / physiology

Substances

  • Interleukin-6
  • SMAD3 protein, human
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Smad3 Protein
  • Transforming Growth Factor beta
  • Epidermal Growth Factor